SUANFARMA strengthens leadership in Nutraceutical Division – SUANNUTRA Anthony Weston appointed as CEO of SUANNUTRA.
SUANNUTRA will enhance its presence in the global nutraceuticals market through strategic focus, product innovation and brand development.
SUANFARMA strengthens leadership in Nutraceutical Division – SUANNUTRA Anthony Weston appointed as CEO of SUANNUTRA.
SUANNUTRA will enhance its presence in the global nutraceuticals market through strategic focus, product innovation and brand development.
SUANFARMA strengthens leadership in Nutraceutical Division – SUANNUTRA Anthony Weston appointed as CEO of SUANNUTRA.
SUANNUTRA will enhance its presence in the global nutraceuticals market through strategic focus, product innovation and brand development.
Metabolaid®, awarded ingredient of the year in the weight management category. Metabolaid® a natural product for multifunctional cardiovascular support.
Continue reading
SupplySide East, the East Coast’s leading ingredients and solutions trade show is back in Secaucus, New Jersey and SUANFARMA will be there.
Continue reading
SUANFARMA participates one more year in Natural Products Expo West 2023. We are waiting for you in Anaheim, California, from March 9th to 11th at booth 3978 where we want to share with all attendees OUR innovative ingredients along with our R&D capabilities for product development.
Continue reading
The increasingly sedentary lifestyle of the world’s population is leading to an increase in the prevalence of overweight and obesity. The WHO estimates that by 2025, 167 million people will have health problems related to being overweight or obese.
Metabolaid® is a patented (ES2661579A1) botanical ingredient based on hibiscus and lemon verbena extracts. Its quality is based on a proprietary lemon verbena extraction process that uniquely concentrates and preserves the active ingredients.
Continue reading
SUANFARMA announces the set-up of its UK Subsidiary, a new strategy aligned with the territorial expansion ambitions of the compañy who due to its international nature, continues to consolidate a strong commercial network, exporting to 75 countries and with more than 3,000 active customers worldwide.
Specifically, the creation of this new subsidiary represents the commitment of SUANFARMA and its Nutra division, with the British market.
“Our aim is to be even closer to our customers, to understand and meet their needs. With this milestone we become a local partner, strengthening our business relationship based on trust, reliability, supply chain management and proactivity” explains Miguel Poza, SUANFARMA´s Nutra Division Director.
Continue reading
Nutraceuticals comprise a wide range of substances and foods that, in addition to their nutritional value, also offer medical or health benefits for the prevention and treatment of diseases. Our colleague Gonzalo Tobaruela, Corporate Development Director of SUANFARMA, will participate in the webinar “Nutraceuticals and Mergers & Acquisitions” together with other selected industry representatives.
Continue reading
Upward trend in the nutraceutical market. Various indicators estimate a growth in the nutraceuticals market in the coming years, with the main markets being the USA, Australia and South Korea. According to a study, spending on vitamins, minerals and food supplements will soar in 2020, at a rate of 75.4%.
Continue reading